IP Library Granted Patent US 12,378,468
Granted Patent B2
US 12,378,468 · App. 18/417,270 · Granted Aug 5, 2025

Organometallic compound, organic light-emitting device including the same and electronic apparatus including the organic light-emitting device

Inventors: Kyuyoung Hwang (Anyang-si, KR); Byungjoon Kang (Seoul, KR); Seungyeon Kwak (Suwon-si, KR); Kum Hee Lee (Suwon-si, KR); Aram Jeon (Seoul, KR); Sukekazu Aratani (Hwaseong-si, KR); Banglin Lee (Suwon-si, KR); Kyuhyun Im (Seongnam-si, KR); Byoungki Choi (Hwaseong-si, KR); Yasushi Koishikawa (Hwaseong-si, KR)
Assignee: SAMSUNG ELECTRONICS CO., LTD.
C09K11/02C07F15/0033C09K11/06H10K85/342C09K2211/1007C09K2211/1029C09K2211/1044C09K2211/1088C09K2211/185H10K50/11H10K50/15H10K50/16H10K50/17H10K50/171H10K50/18H10K2101/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,378,468
App. No.
18/417,270
Granted
Aug 5, 2025
Kind
B2
Abstract

Provided are an organometallic compound represented by Formula 1, an organic light-emitting device including the same and an electronic apparatus including the organic light-emitting device: M(L 1 ) n1 (L 2 ) n2   <Formula 1> wherein M, L 1 , L 2 , n1, and n2 in Formula 1 are the same as described in the detailed description.

Claims (147)

1. An organometallic compound represented by Formula 1:

M(L 1 ) n-1 (L 2 ) n-2   <Formula 1>

wherein, in Formula 1,

M is a transition metal,

L 1 is a ligand represented by Formula 2,

L 2 is a ligand represented by Formula 3,

n1 and n2 are each independently 1 or 2, wherein when n1 is 2, two L 1 (s) are identical to or different from each other, and when n2 is 2, two L 2 (s) are identical to or different from each other,

wherein, in Formulae 2 and 3,

Y 21 is C or N,

ring CY 2 is a C 5 -C 30 carbocyclic group or a C 1 -C 30 heterocyclic group,

X 11 is Si,

X 1 is O, S, Se, N(Z 19 ), C(Z 19 )(Z 20 ), or Si(Z 19 )(Z 20 ),

A 21 to A 24 are each independently C or N,

L 3 is a single bond, a C 5 -C 30 carbocyclic group unsubstituted or substituted with at least one R 10a , or a C 1 -C 30 heterocyclic group unsubstituted or substituted with at least one R 10a ,

R 2 , R 11 to R 16 , Z 1 to Z 3 , Z 19 , and Z 20 are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, —SF 5 , a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 1 -C 60 alkylthio group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —N(Q 1 )(Q 2 ), —Si(Q 3 )(Q 4 )(Q 5 ), —Ge(Q 3 )(Q 4 )(Q 5 ), —B(Q 6 )(Q 7 ), —P(═O)(Q 8 )(Q 9 ), or —P(Q 8 )(Q 9 ),

a2 is an integer from 0 to 20, and when a2 is 2 or more, two or more R 2 (s) are identical to or different from each other,

b1 is an integer from 0 to 6, and when b1 is 2 or more, two or more Z 1 (s) are identical to or different from each other,

b2 is an integer from 0 to 4, and when b2 is 2 or more, two or more Z 2 (s) are identical to or different from each other,

R 11 and R 12 are optionally linked to form a C 5 -C 30 carbocyclic group unsubstituted or substituted with at least one R 10a , or a C 1 -C 30 heterocyclic group unsubstituted or substituted with at least one R 10a ,

two or more of a plurality of R 2 (s) are optionally linked to form a C 5 -C 30 carbocyclic group unsubstituted or substituted with at least one R 10a or a C 1 -C 30 heterocyclic group unsubstituted or substituted with at least one R 10a ,

two or more of a plurality of Z 1 (s) are optionally linked to form a C 5 -C 30 carbocyclic group unsubstituted or substituted with at least one R 10a or a C 1 -C 30 heterocyclic group unsubstituted or substituted with at least one R 10a ,

two or more of a plurality of Z 2 (s) are optionally linked to form a C 5 -C 30 carbocyclic group unsubstituted or substituted with at least one R 10a or a C 1 -C 30 heterocyclic group unsubstituted or substituted with at least one R 10a ,

R 10a is the same as defined in connection with Z 1 ,

* and *′ each indicate a binding site to M in Formula 1,

provided that at least one of i) to v) is true:

i) b1 is at least one and the at least one Z 1 is C 1 -C 3 alkyl group unsubstituted or substituted with at least one deuterium,

ii) b2 is at least one and the at least one Z 2 is —CD 3 ,—CD 2 H, —CDH 2 or —CH3,

iii) at least one of R 2 , R 11 , R 12 and R 13 is deuterium; —CD 3 ; —CD 2 H; —CDH 2 ; a substituted or unsubstituted C 2 -C 60 alkyl group; or a substituted or unsubstituted C 6 -C 60 aryl group,

iv) R 2 is deuterium, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, or a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, and at least one of R 11 , R 12 and R 13 is deuterium, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, or a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group,

v) a group represented by *-L 3 -Z 3 is a group represented Formula 9-3, 10-12, 10-19, 10-45, 10-48, 10-59, 10-62, 10-70 or 10-121,

a substituent of the substituted C 1 -C 60 alkyl group, the substituted C 2 -C 60 alkenyl group, the substituted C 2 -C 60 alkynyl group, the substituted C 1 -C 60 alkoxy group, the substituted C 1 -C 60 alkylthio group, the substituted C 3 -C 10 cycloalkyl group, the substituted C 1 -C 10 heterocycloalkyl group, the substituted C 3 -C 10 cycloalkenyl group, the substituted C 1 -C 10 heterocycloalkenyl group, the substituted C 6 -C 60 aryl group, the substituted C 6 -C 60 aryloxy group, the substituted C 6 -C 60 arylthio group, the substituted C 1 -C 60 heteroaryl group, the substituted monovalent non-aromatic condensed polycyclic group, and the substituted monovalent non-aromatic condensed heteropolycyclic group is:

deuterium, —F, —Cl, —Br, —I, —CD 3 , —CD 2 H, —CDH 2 , —CF 3 , —CF 2 H, —CFH 2 , a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, or a C 1 -C 60 alkylthio group;

a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, or a C 1 -C 60 alkylthio group, each substituted with deuterium, —F, —Cl , —Br, —I, —CD 3 , —CD 2 H, —CDH 2 , —CF 3 , —CF 2 H, —CFH 2 , a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —N(Q 11 )(Q 12 ), —Si(Q 13 )(Q 14 ) (Q 15 ), —Ge(Q 13 )(Q 14 )(Q 15 ), —B(Q 16 )(Q 17 ), —P(═O)(Q 18 )(Q 19 ), —P(Q 18 )(Q 19 ), or any combination thereof;

a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, or a monovalent non-aromatic condensed heteropolycyclic group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, —CD 3 , —CD 2 H, —CDH 2 , —CF 3 , —CF 2 H, —CFH 2 , a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 1 -C 60 alkylthio group, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —N(Q 21 )(Q 22 ), —Si(Q 23 )(Q 24 )(Q 25 ), —Ge(Q 23 )(Q 24 )(Q 25 ), —B(Q 26 )(Q 27 ), —P(═O)(Q 28 )(Q 29 ), —P(Q 28 )(Q 29 ), or any combination thereof;

—N(Q 31 )(Q 32 ), —Si(Q 33 )(Q 34 )(Q 35 ), —Ge(Q 33 )(Q 34 )(Q 35 ), —B(Q 36 )(Q 37 ), —P(═O)(Q 38 )(Q 39 ), or —P(Q 38 )(Q 39 ); or

any combination thereof,

wherein Q 1 to Q 9 , Q 11 to Q 19 , Q 21 to Q 29 , and Q 31 to Q 39 are each independently hydrogen; deuterium; —F; —Cl; —Br; —I; a hydroxyl group; a cyano group; a nitro group; an amidino group; a hydrazine group; a hydrazone group; a carboxylic acid group or a salt thereof; a sulfonic acid group or a salt thereof; a phosphoric acid group or a salt thereof; a C 1 -C 60 alkyl group, unsubstituted or substituted with deuterium, —F, a C 1 -C 60 alkyl group, a C 6 -C 60 aryl group, or any combination thereof; a C 2 -C 60 alkenyl group; a C 2 -C 60 alkynyl group; a C 1 -C 60 alkoxy group; a C 1 -C 60 alkylthio group; a C 3 -C 10 cycloalkyl group; a C 1 -C 10 heterocycloalkyl group; a C 3 -C 10 cycloalkenyl group; a C 1 -C 10 heterocycloalkenyl group; a C 6 -C 60 aryl group, unsubstituted or substituted with deuterium, —F, a C 1 -C 60 alkyl group, a C 6 -C 60 aryl group, or any combination thereof; a C 6 -C 60 aryloxy group; a C 6 -C 60 arylthio group; a C 1 -C 60 heteroaryl group; a monovalent non-aromatic condensed polycyclic group; or a monovalent non-aromatic condensed heteropolycyclic group.

2. The organometallic compound of claim 1 , wherein

ring CY 2 is a benzene group, a naphthalene group, an anthracene group, a phenanthrene group, a 1,2,3,4-tetrahydronaphthalene group, a carbazole group, a fluorene group, a dibenzosilole group, a dibenzothiophene group, or a dibenzofuran group.

3. The organometallic compound of claim 1 , wherein

L 3 in Formula 1 is:

a single bond; or

a benzene group, a naphthalene group, a dibenzofuran group, or a dibenzothiophene group, each unsubstituted or substituted with deuterium, —F, a cyano group, a C 1 -C 20 alkyl group, a deuterated C 1 -C 20 alkyl group, a fluorinated C 1 -C 20 alkyl group, a C 3 -C 10 cycloalkyl group, a deuterated C 3 -C 10 cycloalkyl group, a fluorinated C 3 -C 10 cycloalkyl group, a (C 1 -C 20 alkyl)C 3 -C 10 cycloalkyl group, a phenyl group, a deuterated phenyl group, a fluorinated phenyl group, a (C 1 -C 20 alkyl)phenyl group, a naphthyl group, a pyridinyl group, a furanyl group, a thiophenyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, or any combination thereof.

4. The organometallic compound of claim 1 , wherein

R 2 , R 11 to R 13 , Z 1 to Z 3 , Z 19 and Z 20 in Formulae 2 and 3 are each independently:

hydrogen, deuterium, —F, or a cyano group; or

a C 1 -C 20 alkyl group, a C 3 -C 10 cycloalkyl group, a phenyl group, a naphthyl group, a pyridinyl group, a furanyl group, a thiophenyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, or a dibenzothiophenyl group, each unsubstituted or substituted with deuterium, —F, a cyano group, a C 1 -C 20 alkyl group, a deuterated C 1 -C 20 alkyl group, a fluorinated C 1 -C 20 alkyl group, a C 3 -C 10 cycloalkyl group, a deuterated C 3 -C 10 cycloalkyl group, a fluorinated C 3 -C 10 cycloalkyl group, a (C 1 -C 20 alkyl)C 3 -C 10 cycloalkyl group, a phenyl group, a deuterated phenyl group, a fluorinated phenyl group, a (C 1 -C 20 alkyl)phenyl group, a naphthyl group, a pyridinyl group, a furanyl group, a thiophenyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, —Si(Q 33 )(Q 34 )(Q 35 ), —Ge(Q 33 )(Q 34 )(Q 35 ), or any combination thereof, and

R 14 to R 16 in Formula 2 are each independently a C 1 -C 20 alkyl group, a C 3 -C 10 cycloalkyl group, a phenyl group, a naphthyl group, a pyridinyl group, a furanyl group, a thiophenyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, or a dibenzothiophenyl group, each unsubstituted or substituted with deuterium, —F, a cyano group, a C 1 -C 20 alkyl group, a deuterated C 1 -C 20 alkyl group, a fluorinated C 1 -C 20 alkyl group, a C 3 -C 10 cycloalkyl group, a deuterated C 3 -C 10 cycloalkyl group, a fluorinated C 3 -C 10 cycloalkyl group, a (C 1 -C 20 alkyl)C 3 -C 10 cycloalkyl group, a phenyl group, a deuterated phenyl group, a fluorinated phenyl group, a (C 1 -C 20 alkyl)phenyl group, a naphthyl group, a pyridinyl group, a furanyl group, a thiophenyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, or any combination thereof.

5. The organometallic compound of claim 1 , wherein

R 11 is not hydrogen.

6. The organometallic compound of claim 1 , wherein satisfying at least one of <Condition A>and <Condition B>:

<Condition A>

L 3 is a C 5 -C 30 carbocyclic group unsubstituted or substituted with at least one R 10a , or a C 1 -C 30 heterocyclic group unsubstituted or substituted with at least one R 10a ,

<Condition B>

Z 3 is a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, or a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group.

7. The organometallic compound of claim 1 , wherein

a group represented by

in Formulae 2 is a group represented by one of Formulae CY2-1 to CY2-33:

wherein, in Formulae CY2-1 to CY2-33,

Y 21 and R 2 are the same as described in claim 1 ,

X 22 is C(R 22 )(R 23 ), N(R 22 ), O, S, or Si(R 22 )(R 23 ),

R 22 to R 29 are the same as described in connection with R 2 in claim 1 ,

a28 is an integer from 0 to 8,

a26 is an integer from 0 to 6,

a24 is an integer from 0 to 4,

a23 is an integer from 0 to 3,

a22 is an integer from 0 to 2,

*” indicates a binding site to a neighboring atom in Formula 2, and

* indicates a binding site to M in Formula 1.

8. The organometallic compound of claim 1 , wherein

a group represented by

in Formula 3 is a group represented by one of Formulae CY3-1 to CY3-6:

wherein, in Formulae CY3-1 to CY3-6,

X 1 , Z 1 , and b1 are the same as described in claim 1 ,

* indicates a binding site to M in Formula 1, and

*” indicates a binding site to a neighboring atom in Formula 3.

9. The organometallic compound of claim 1 , wherein

a group represented by

in Formula 3 is a group represented by one of Formulae CY3-1A to CY3-1D, CY3-2A to CY3-2D, CY3-3A to CY3-3D, CY3-4A to CY3-4D, CY3-5A to CY3-5D, and CY3-6A to CY3-6D:

wherein, in Formulae CY3-1A to CY3-1D, CY3-2A to CY3-2D, CY3-3A to CY3-3D, CY3-4A to CY3-4D, CY3-5A to CY3-5D, and CY3-6A to CY3-6D,

X 1 and Z 1 are the same as described in claim 1 ,

ring CY 30 and ring CY 31 are each independently a C 5 -C 30 carbocyclic group or a C 1 -C 30 heterocyclic group,

R 30a and R 31a are each the same as described in connection with R 10a in claim 1 ,

b12 may be an integer from 0 to 2,

b14 may be an integer from 0 to 4,

b30 and b31 may each independently be an integer from 0 to 20, when b30 is 2 or more, two or more R 30a (s) may be identical to or different from each other, and when b31 is 2 or more, two or more R 31a (s) may be identical to or different from each other,

* indicates a binding site to M in Formula 1, and

*” indicates a binding site to a neighboring atom in Formula 3.

10. The organometallic compound of claim 1 , wherein

a group represented by

in Formula 3 is a group represented by one of Formulae CY3(1) to CY3(132):

wherein, in Formulae CY3(1) to CY3(132),

X 1 is the same as described in claim 1 ,

Z 11 to Z 18 are the same as described in connection with Z 1 in claim 1 , and each of Z 11 to Z 18 is not hydrogen,

* indicates a binding site to M in Formula 1, and

*” indicates a binding site to a neighboring atom in Formula 3.

11. The organometallic compound of claim 1 , wherein

a group represented by

in Formula 3 is a group represented by one of Formulae CY4-1 to CY4-60:

wherein, in Formulae CY4-1 to CY4-60,

L 3 and Z 3 are the same as described in claim 1 ,

Z 21 to Z 24 are the same as described in connection with Z 2 in claim 1 , and each of Z 21 to Z 24 is not hydrogen,

*′ indicates a binding site to M in Formula 1, and

*” indicates a binding site to a neighboring atom in Formula 3.

12. The organometallic compound of claim 1 , wherein

a group represented by

in Formula 3 is a group represented by one of Formulae CY4(1) to CY4(4):

wherein, in Formulae CY4(1) to CY4(4),

A 21 to A 24 , L 3 , Z 2 , Z 3 and R 10a are the same as described in claim 1 ,

b22 is an integer from 0 to 2,

ring CY 10 and ring CY 11 are each independently a C 5 -C 30 carbocyclic group or a C 1 -C 30 heterocyclic group,

R 11a is the same as described in connection with R 10a ,

b3 and b4 are each independently an integer from 0 to 20, when b3 is 2 or more, two or more R 10a (s) are identical to or different from each other, and when b4 is 2 or more, two or more R 11a (s) are identical to or different from each other,

*′ indicates a binding site to M in Formula 1, and

*” indicates a binding site to a neighboring atom in Formula 3.

13. The organometallic compound of claim 1 , wherein

a group represented by

in Formula 3 is a group represented by one of Formulae CY4(1)-1 to CY4(1)-4, CY4(2)-1 to CY4(2)-4, CY4(3)-1 to CY4(3)-4 and CY4(4)-1:

wherein, in Formulae CY4(1)-1 to CY4(1)-4, CY4(2)-1 to CY4(2)-4, CY4(3)-1 to CY4(3)-4 and CY4(4)-1,

A 21 to A 24 , L 3 , Z 2 , Z 3 and R 10a are the same as described in claim 1 ,

b22 is an integer from 0 to 2,

R 11a is the same as described in connection with R 10a ,

b34 and b44 may each independently be an integer from 0 to 4, when b34 is 2 or more, two or more R 10a (s) may be identical to or different from each other, and when b44 is 2 or more, two or more R 11a (s) may be identical to or different from each other,

b36 may be an integer from 0 to 6, when b36 is 2 or more, two or more R 10a (s) may be identical to or different from each other,

*′ indicates a binding site to M in Formula 1, and

*” indicates a binding site to a neighboring atom in Formula 3.

14. The organometallic compound of claim 1 , wherein

an absolute value of a difference of a highest occupied molecular orbital energy level of the organometallic compound and a lowest unoccupied molecular orbital energy level of the organometallic compound is about 3.48 eV and or more.

15. The organometallic compound of claim 1 , wherein

an absolute value of a difference of a highest occupied molecular orbital energy level of the organometallic compound and a lowest unoccupied molecular orbital energy level of the organometallic compound divided by T 1 energy level of the organometallic compound is about 1.364 eV and or more.

16. An organic light-emitting device comprising:

a first electrode;

a second electrode; and

an organic layer located between the first electrode and the second electrode and comprising an emission layer,

wherein the organic layer comprises at least one of the organometallic compound of claim 1 .

17. The organic light-emitting device of claim 16 , wherein

the first electrode is an anode,

the second electrode is a cathode,

the organic layer comprises a hole transport region between the first electrode and the emission layer and an electron transport region between the emission layer and the second electrode,

the hole transport region comprises a hole injection layer, a hole transport layer, an electron blocking layer, a buffer layer, or any combination thereof, and

the electron transport region comprises a hole blocking layer, an electron transport layer, an electron injection layer, or any combination thereof.

18. The organic light-emitting device of claim 16 , wherein

the organometallic compound is included in the emission layer.

19. The organic light-emitting device of claim 18 , wherein

the emission layer emits green light.

20. The organic light-emitting device of claim 18 , wherein

the emission layer further comprises a host and the amount of the host is greater than the amount of the organometallic compound.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2025
From: SAMSUNG ELECTRONICS CO., LTD.
To: SAMSUNG DISPLAY CO., LTD.
Reel/Frame 072524/0231 →
Priority Claims (2)
KR 10-2019-0113025 · Sep 11, 2019 · national
KR 10-2020-0114307 · Sep 8, 2020 · national
Continuity (3)
Continuation 18311654 · May 3, 2023
Continuation 17016806 · Sep 10, 2020
Related Publication 20240215433A1 · Jun 27, 2024
References Cited (79)
US 7429426B2 · Brown et al. · 2008 [cited by applicant]
US 8431243B2 · Kwong et al. · 2013 [cited by applicant]
US 10135009B2 · Hwang et al. · 2018 [cited by applicant]
US 12010909B2 · Hwang · 2024 [cited by examiner]
US 12069940B2 · Hwang · 2024 [cited by examiner]
US 20130181190A1 · Ma et al. · 2013 [cited by applicant]
US 20130334521A1 · Lee et al. · 2013 [cited by applicant]
US 20140008617A1 · Beers et al. · 2014 [cited by applicant]
US 20150021585A1 · Yu et al. · 2015 [cited by applicant]
US 20150090974A1 · Kim et al. · 2015 [cited by applicant]
US 20150179959A1 · Lin et al. · 2015 [cited by applicant]
US 20160093814A1 · Hwang et al. · 2016 [cited by applicant]
US 20160111663A1 · Kim et al. · 2016 [cited by applicant]
US 20160111665A1 · Kim et al. · 2016 [cited by applicant]
US 20160118604A1 · Choi et al. · 2016 [cited by applicant]
US 20160155962A1 · Hwang et al. · 2016 [cited by applicant]
US 20160155963A1 · Hwang et al. · 2016 [cited by applicant]
US 20160164012A1 · Lee et al. · 2016 [cited by applicant]
US 20160181530A1 · Choi et al. · 2016 [cited by applicant]
US 20160268519A1 · Choi et al. · 2016 [cited by applicant]
US 20160268521A1 · Lee et al. · 2016 [cited by applicant]
US 20160268522A1 · Hwang et al. · 2016 [cited by applicant]
US 20170054095A1 · Choi et al. · 2017 [cited by applicant]
US 20170288157A1 · Joseph · 2017 [cited by applicant]
US 20170346025A1 · Hwang et al. · 2017 [cited by applicant]
US 20180013077A1 · Boudreault et al. · 2018 [cited by applicant]
US 20180013078A1 · Lee et al. · 2018 [cited by applicant]
US 20180097185A1 · Su et al. · 2018 [cited by applicant]
US 20180114928A1 · Lee et al. · 2018 [cited by applicant]
US 20180309070A1 · Lee et al. · 2018 [cited by applicant]
US 20190074457A1 · Choi et al. · 2019 [cited by applicant]
US 20190189934A1 · Liou et al. · 2019 [cited by applicant]
US 20200161563A1 · Jang et al. · 2020 [cited by applicant]
US 20200212323A1 · Hwang et al. · 2020 [cited by applicant]
US 20200259107A1 · Xia et al. · 2020 [cited by applicant]
US 20200287144A1 · Hwang et al. · 2020 [cited by applicant]
US 20200358012A1 · Lee et al. · 2020 [cited by applicant]
US 20210054010A1 · Tsai et al. · 2021 [cited by applicant]
US 20210083207A1 · Lee et al. · 2021 [cited by applicant]
US 20210179649A1 · Liou et al. · 2021 [cited by applicant]
US 20220140259A1 · Tsai et al. · 2022 [cited by applicant]
US 20220177492A1 · Fleetham et al. · 2022 [cited by applicant]
US 20220181561A1 · Fleetham et al. · 2022 [cited by applicant]
US 20220190259A1 · Park et al. · 2022 [cited by applicant]
US 20220298191A1 · Lee et al. · 2022 [cited by applicant]
US 20220344600A1 · Lee et al. · 2022 [cited by applicant]
US 20220399517A1 · Fleetham et al. · 2022 [cited by applicant]
US 20220402952A1 · Kwak et al. · 2022 [cited by applicant]
US 20230128713A1 · Lee et al. · 2023 [cited by applicant]
CN 106432345A · 2017 [cited by applicant]
CN 107098938A · 2017 [cited by applicant]
CN 107573383A · 2018 [cited by applicant]
CN 109422778A · 2019 [cited by applicant]
CN 109928996A · 2019 [cited by applicant]
EP 2465912A1 · 2012 [cited by applicant]
EP 3010067A · 2016 [cited by applicant]
EP 3010068A1 · 2016 [cited by applicant]
EP 3904363A1 · 2021 [cited by applicant]
KR 20120114030A · 2012 [cited by applicant]
KR 20130084615A · 2013 [cited by applicant]
KR 20160046296A · 2016 [cited by applicant]
KR 1020160037007A · 2016 [cited by applicant]
KR 1020160064955A · 2016 [cited by applicant]
KR 20160109909A · 2016 [cited by applicant]
KR 1020160109907A · 2016 [cited by applicant]
KR 1020160109908A · 2016 [cited by applicant]
KR 1020180020878A · 2018 [cited by applicant]
WO 2014007565A1 · 2014 [cited by applicant]
English Abstract of KR 10-2018-0020878. [cited by applicant]
English Translation of Office Action dated Jun. 21, 2023, issued in corresponding KR Patent Application No. 10-2020-0114307, 6 pp. [cited by applicant]
English Translation of Office Action dated Nov. 29, 2023, issued in corresponding CN Patent Application No. 202010950227.8, 8 pp. [cited by applicant]
Extended European Search Report dated Jan. 14, 2021, issued in EP Patent Application No. 20195031.8. [cited by applicant]
Office Action dated Aug. 29, 2022 issued in corresponding EP Patent Application No. 20195031.8, 11 pp. [cited by applicant]
Office Action dated Jun. 21, 2023, issued in corresponding KR Patent Application No. 10-2020-0114307, 7 pp. [cited by applicant]
Office Action dated Nov. 29, 2023, issued in corresponding CN Patent Application No. 202010950227.8, 7 pp. [cited by applicant]
English Translation of Office Action dated Dec. 20, 2024, issued in corresponding KR Patent Application No. 10-2024-0000485, 4 pp. [cited by applicant]
English Translation of Office Action dated Dec. 20, 2024, issued in corresponding KR Patent Application No. 10-2024-0000486, 5 pp. [cited by applicant]
Office Action dated Dec. 20, 2024, issued in corresponding KR Patent Application No. 10-2024-0000486, 5 pp. [cited by applicant]
Office Action dated Dec. 20, 2024, issued in corresponding KR Patent Application No. 10-2024-0000485, 6 pp. [cited by applicant]